Navigation Links
Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
Date:4/25/2008

's URL address field. Remove the space if one exists.)

Notes to editors

Shire Plc

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com

The "Safe Harbor" Statement Under The Private Securities Litigation Reform Act Of 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA(R) (Human TGF beta 3) and velaglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM)(lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products including, but not limited to, the impact of thos
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
3. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
4. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
5. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
6. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
7. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
8. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
9. ITSSD: Russia Can Secure Greatest Biotech Market Advances Following US, Not EU Innovation Model
10. Optherion, Inc. Completes $37 Million Start Up Financing
11. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... The Center for Business Intelligence (CBI), a ... announce the full agenda for the ... . The forum will take place at ... ,, Over 1,500 senior-level Finance, Accounting, Audit ... event since its inception, and this year,s ...
(Date:12/15/2009)... has announced the launch of several innovative new programs ... in the current economic climate. The first is ... finance legal services over a period of 6, 12, ... their start-up companies. The second is aimed at ... arrangements over 6 to 12 month period at discounted ...
(Date:12/14/2009)... Patrick Kennedy Joins with State Biotech Leaders ... in Research and Development while Boosting Rhode ... ,, PROVIDENCE, R.I., Dec. 14 /PRNewswire-USNewswire/ ... leaders in research, medicine and biotechnology gathered ... to discuss the importance of medical innovation ...
(Date:12/14/2009)... -- Nektar Therapeutics (Nasdaq: NKTR ) announced ... serve on its board of directors. Winger ... 35 years of experience in corporate management, financial ... extensive industry perspective at an important time in ... and CEO of Nektar and member of the ...
Breaking Biology Technology:CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... MORRISTOWN, N.J., March 26 Vicus Therapeutics, ... K. Rao, Vice President Clinical Research and ... Institute,s 15th International,Molecular Medicine Tri-Conference on March ... North Convention Center in San Francisco. Dr. ...
... (Nasdaq: TPTX ) today announced financial results for ... the full year 2007,the Company posted revenue of $9.9 ... cash equivalents totaled $32.5 million at December 31, 2007., ... development programs,in 2007," said Neil Kurtz, M.D., President and ...
... PHST ), a leading provider of software, strategic,consulting, ... that it will be presenting at B. Riley & ... 2008 at the Palms Las,Vegas. Shawn O,Connor, Pharsight,s President ... will be presenting on April 2nd,at 1:30 p.m. PT., ...
Other Biology Technology:TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 2TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 3TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 4TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 5TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 6TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights 7Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference 2
(Date:12/15/2009)... WI, December 15, 2009 Economics, environmental impacts, ... factors that influence the overall success of an ... on the system, forcing individuals and social groups ... order to survive. , Experiential learning theory ... result of firsthand experiences. Such lessons are especially ...
(Date:12/15/2009)... ancient American horses may have been grazing the ... than previously thought. After plucking ancient DNA from ... researchers used cutting-edge techniques to uncover "genetic fossils" ... to between 7,600 and 10,500 calendar years. This ... of these now-extinct mammals endured longer in the ...
(Date:12/15/2009)... German . , Leipzig: Species distribution models are ... of mammals. This is the finding of a study ... The researchers analysed data on species distribution, climate, land ... of the species. Judging by the large differences in ... to adapt fast to changing climatic conditions. This in ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Species distribution models are of only limited value for predicting future mammal distributions 2VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 1VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 2VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 3Americans Spend Billions on Alternative Medicine 53255 1Americans Spend Billions on Alternative Medicine 53255 2Americans Spend Billions on Alternative Medicine 53255 3FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 1FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 2FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 3FDA Approves TYVASO 28Treprostinil 29 Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension 53251 4
... biological attributes, is shaped by evolution through environmental ... are in other ways very similar might respond ... world slightly differently, using photoreceptors that are attuned ... special group of closely-related fish species inhabiting the ...
... By investigating the interplay between pheromone signaling and behavior ... an adult fly's earlier experience as a young individual ... adult. In particular, the researchers found that pheromone signals ... influence how young flies will behave once they reach ...
... tetrahydrocannabinol--has a well-documented tendency to stimulate hunger. ... to cannabinoid receptors in the brain, they ... circuitry underlying this effect. , Understanding this ... the cannabinoid receptor, CB1, offers a promising ...
Other Biology News:Multiple genes permit closely related fish species to mix and match their color vision 2Past experience of pheromones induces dominant courtship behavior in fruit flies 2Machinery of the 'marijuana munchies' 2
...
... designed to rapidly and reliably amplify ... patented APA Technology. APAgene provides hassle-free, ... competitive price. All necessary ingredients are ... Kit can be used for identifying ...
... designed to deparaffinize and perform Heat Induced ... tissue sections mounted on glass microscope slides. ... at the high temperature used in HIER ... the paraffin by detergent. Formaldehyde fixation impairs ...
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
Biology Products: